CDK4 and nasopharyngeal carcinoma: This in turn suppressed cell proliferation and inducing chemotherapy sensitivity by controlling c-Myc/CCND1/CDK4/E2F1 signaling, and suggested an abnormal automodulatory feedback loop of CDK4-c-Myc-miR-15a which promoted NPC pathogenesis and acquired DDP resistance.